Menu
GWAS Study

Genome-wide association study of coronary and aortic calcification implicates risk loci for coronary artery disease and myocardial infarction.

van Setten J, Isgum I, Smolonska J et al.

23561647 PubMed ID
GWAS Study Type
2620 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

VS
van Setten J
II
Isgum I
SJ
Smolonska J
RS
Ripke S
DJ
de Jong PA
OM
Oudkerk M
DK
de Koning H
LJ
Lammers JW
ZP
Zanen P
GH
Groen HJ
BH
Boezen HM
PD
Postma DS
WC
Wijmenga C
VM
Viergever MA
MW
Mali WP
DB
de Bakker PI
Chapter II

Abstract

Summary of the research findings

Arterial calcification is a well-known risk factor for coronary artery disease (CAD) and myocardial infarction (MI). We performed a genome-wide association study on coronary artery calcification and aortic calcification as intermediate traits for CAD/MI. We tested ∼2.5 million SNPs for association with coronary artery calcification and aortic calcification in 2620 male individuals of the NELSON trial, who underwent chest CT scans. All participants were current or former heavy smokers. No SNPs were associated with aortic calcification on a genome-wide scale. The 9p21 locus was significantly associated with coronary artery calcification (rs1537370, P = 2.3 × 10(-11)). Since this locus corresponds to the strongest SNP association for CAD/MI, we tested 24 published and validated CAD/MI risk SNPs for association with arterial calcification. Besides the CAD/MI SNP at 9p21 (rs4977574, P = 3.1 × 10(-10)), two additional loci at ADAMTS7 (rs3825807, P = 6.5 × 10(-6)) and at PHACTR1 (rs12526453, P = 1.0 × 10(-3)) show a nominally significant association with coronary artery calcification with MI/CAD risk alleles increasing the degree of arterial calcification. The 9p21 locus was also nominally associated with aortic calcification (P = 3.2 × 10(-4)). These findings indicate that these CAD and MI risk loci are likely involved in arterial calcification.

2,620 European ancestry males

Chapter III

Study Statistics

Key metrics and study information

2620
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
Netherlands
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.